These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 912916)

  • 1. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of a specific antiserum by synthetic C-terminal fragment of glucagon.
    Ohneda A; Watanabe K; Wakimatsu M; Fujino M
    Horm Metab Res; 1979 Aug; 11(8):463-8. PubMed ID: 574120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.
    Imagawa K; Nishino T; Shin S; Uehata S; Hashimura E; Yanaihara C; Yanaihara N
    Endocrinol Jpn; 1979 Feb; 26(1):123-31. PubMed ID: 86440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G can cross-react with glucagon antisera and cause a spuriously high plasma immunoreactive glucagon level.
    Hattori N; Saiki Y; Kajikawa M; Ishihara T; Moridera K; Hino M; Ikekubo K; Kurahachi H
    Endocr J; 1995 Aug; 42(4):455-60. PubMed ID: 8556050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of glucagon in the gastrointestinal tract.
    Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
    J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size heterogeneity of immunoreactive glucagon during bile-duct obstruction in the rabbit.
    Sanke T
    Endocrinol Jpn; 1982 Oct; 29(5):541-51. PubMed ID: 6763562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of antisera to des Asn28 Thr29 Homoser27-glucagon; the development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma.
    Nishino T; Kodaira T; Shin S; Imagawa K; Yanaihara N; Shima K; Kumahara Y
    Endocrinol Jpn; 1981 Aug; 28(4):419-27. PubMed ID: 6897834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioligand assay: method and application. II. Effect of glucagon coupling on the production of glucagon antisera with suitable binding parameters for radioimmunoassay].
    Ziegler M; Keilacker H; Woltanski KP; Besch W; Schubert J
    Acta Biol Med Ger; 1980; 39(2-3):305-14. PubMed ID: 6775484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the physiological role of glucagon. Passive immunization with antiserum specific for pancreatic glucagon in rats.
    Nishino T; Shima K; Shimomura Y; Tanaka R; Kodaira T; Imagawa K; Kumahara Y
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():109-13. PubMed ID: 7227314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment.
    Nishino T; Kodaira T; Shin S; Imagawa K; Shima K; Kumahara Y; Yanaihara C; Yanaihara N
    Clin Chem; 1981 Oct; 27(10):1690-7. PubMed ID: 6169468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of N-terminally and C-terminally directed monoclonal antibodies against pancreatic glucagon.
    Gregor M; Riecken EO
    Gastroenterology; 1985 Sep; 89(3):571-80. PubMed ID: 3839481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.
    Doi K; Prentki M; Yip C; Muller WA; Jeanrenaud B; Vranic M
    J Clin Invest; 1979 Mar; 63(3):525-31. PubMed ID: 429572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma glucagon in alcoholic cirrhosis: cross reaction with IgG].
    Gonvers JJ; Múller W; Maeder E; Felber JP; Hofstetter JR; Loizeau E
    Schweiz Med Wochenschr; 1980 May; 110(22):871-3. PubMed ID: 7403820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and evaluation of antibodies for radioimmunoassay of secretin.
    Fahrenkrug J; Muckadell OB; Rehfeld JF
    Scand J Clin Lab Invest; 1976 May; 36(3):281-7. PubMed ID: 940982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and evaluation of glucagon antibodies for radioimmunoassay.
    Holst JJ; Aasted B
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):715-26. PubMed ID: 4479706
    [No Abstract]   [Full Text] [Related]  

  • 19. High titer glucagon antisera.
    Tager HS; Hohenboken M; Markese J
    Endocrinology; 1977 Feb; 100(2):367-72. PubMed ID: 832629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature of plasma immunoreactive glucagon in man.
    Shima K; Matsuyama T; Tarui S; Nishikawa M
    Endocrinol Jpn; 1972 Oct; 19(5):495-9. PubMed ID: 4678857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.